Literature DB >> 17237701

Malignant oncocytoma of the lacrimal sac as an unusual cause of epiphora.

Hunter K L Yuen1, W Cheuk, Andy C O Cheng, Chan Anh, Nongnart Chan.   

Abstract

A 72-year-old man presented with a 2-year history of epiphora. CT revealed an extensive inferomedial orbital tumor connected to the lacrimal sac and duct. Incisional biopsy revealed malignant oncocytoma of the lacrimal sac. The patient was treated with exenteration and maxillectomy followed by a course of postoperative radiotherapy. Patients with malignant oncocytoma may present with simple epiphora in absence of other signs and symptoms such as blood stained tearing or purulent rhinorrhea.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17237701     DOI: 10.1097/IOP.0b013e31802dd7f4

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  5 in total

1.  A case of primary oncocytic adenocarcinoma of the lacrimal sac.

Authors:  Jingxue Zhang; Ningli Wang; Jitong Shi; Xin Ge
Journal:  BMJ Case Rep       Date:  2009-07-12

2.  Oncocytic lesions of the ocular adnexa: A review of the histopathology with a brief discussion of the pathogenesis.

Authors:  John G Heathcote; Curtis W Archibald; Alejandra A Valenzuela
Journal:  Saudi J Ophthalmol       Date:  2022-04-18

3.  Androgen receptor-positive ductal adenocarcinoma of the nasolacrimal duct: A case report.

Authors:  In Ah Park; Ho-Seok Sa; Yoo-Sam Chung; Kyung-Ja Cho
Journal:  Am J Ophthalmol Case Rep       Date:  2016-11-14

4.  Excision of an unusual tumour of oncocytic origin: a case report.

Authors:  William B Howden; Dakshika A Gunaratne; Richard M Gallagher
Journal:  J Surg Case Rep       Date:  2021-05-04

5.  Nasal epithelial myoepithelial carcinoma: An unusual cause of epiphora, a case report and review of the literature.

Authors:  Juliette O Flam; Christopher D Brook; Rachel Sobel; John C Lee; Michael P Platt
Journal:  Allergy Rhinol (Providence)       Date:  2015-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.